Program · Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements
Program 1.1: National Blood Agreement Management
The National Blood Authority is a material statutory entity that manages and coordinates arrangements for the supply of blood and blood-related products and services on behalf of all Australian governments in accordance with the National Blood Agreement. The primary objectives of the National Blood Agreement are to: x provide an adequate, safe, secure and affordable supply of blood, and blood-related products and services x promote the safe, high quality management and use of blood and blood-related products and services in Australia.
National Blood Authority, 2026-27 Portfolio Budget Statements, PDF page 11 reported
$2.5bn
2026-27 Budget estimate
+$327m (+15.3%) on 2025-26 estimated actual
Traced to named suppliers and grant recipients
AusTender and GrantConnect record the agency, not the program, so contracts and grants are shown on the entity page.
Published lines
Each row is one line of the program’s expense table in the 2026-27 Portfolio Budget Statements – Program Expense Line Items, as published.
| Line | Kind | 2025-26 estimated actual |
2026-27 Budget estimate |
Change | Treatment | Source |
|---|---|---|---|---|---|---|
| National Blood Authority Account | administered | $2.1bn | $2.5bn | +$327m +15.4% | reported | 2.1.1 Prog Exp, row 731 |
| National Blood Authority Account | departmental | $15m | $16m | +$1.4m +9.0% | reported | 2.1.1 Prog Exp, row 734 |
| Ordinary annual services | administered | $10m | $13m | +$3.3m +32.2% | reported | 2.1.1 Prog Exp, row 729 |
| Departmental appropriation | departmental | $9.3m | $10m | +$1.2m +13.4% | reported | 2.1.1 Prog Exp, row 732 |
| Expenses not requiring appropriation in the Budget year | departmental | $1.4m | $478k | −$964k −66.9% | reported | 2.1.1 Prog Exp, row 735 |
| to National Managed Fund (Blood and Blood Products) Special Account | administered | $0 | $0 | no change – | reported | 2.1.1 Prog Exp, row 726 |
| National Managed Fund (Blood and Blood Products) Special Account | administered | $0 | $0 | no change – | reported | 2.1.1 Prog Exp, row 727 |
| Operating deficit (surplus) | departmental | $0 | $0 | no change – | reported | 2.1.1 Prog Exp, row 728 |
| to National Blood Authority Account | departmental | −$9.6m | −$11m | −$1.3m – | reported | 2.1.1 Prog Exp, row 733 |
| to National Blood Authority Account | administered | −$10m | −$13m | −$3.3m – | reported | 2.1.1 Prog Exp, row 730 |